메뉴 건너뛰기




Volumn 47, Issue 2, 2016, Pages 107-116

Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: A systematic review and meta-analysis

Author keywords

Acinetobacter baumannii; Meta analysis; Multidrug resistance; Tigecycline; Treatment

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; COLISTIN; IMIPENEM PLUS SULBACTAM; SULBACTAM; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; MINOCYCLINE;

EID: 84956947855     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.11.011     Document Type: Review
Times cited : (83)

References (52)
  • 1
    • 84894471109 scopus 로고    scopus 로고
    • In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii
    • W. Ni, J. Cui, B. Liang, Y. Cai, N. Bai, X. Cai, and et al. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii J Antibiot (Tokyo) 66 2013 705 708
    • (2013) J Antibiot (Tokyo) , vol.66 , pp. 705-708
    • Ni, W.1    Cui, J.2    Liang, B.3    Cai, Y.4    Bai, N.5    Cai, X.6
  • 4
    • 84925267677 scopus 로고    scopus 로고
    • Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance Trial
    • S.C. Kehl, and M.J. Dowzicky Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance Trial J Clin Microbiol 53 2015 1286 1293
    • (2015) J Clin Microbiol , vol.53 , pp. 1286-1293
    • Kehl, S.C.1    Dowzicky, M.J.2
  • 5
    • 76249124162 scopus 로고    scopus 로고
    • Off-label use of antibiotics in hospitalized patients: focus on tigecycline
    • D. Curcio Off-label use of antibiotics in hospitalized patients: focus on tigecycline J Antimicrob Chemother 64 2009 1344 1346
    • (2009) J Antimicrob Chemother , vol.64 , pp. 1344-1346
    • Curcio, D.1
  • 6
    • 54349085650 scopus 로고    scopus 로고
    • Indications of a new antibiotic in clinical practice: results of the Tigecycline Initial Use Registry
    • D. Curcio, F. Fernández, A. Cané, L. Barcelona, and D. Stamboulian Indications of a new antibiotic in clinical practice: results of the Tigecycline Initial Use Registry Braz J Infect Dis 12 2008 198 201
    • (2008) Braz J Infect Dis , vol.12 , pp. 198-201
    • Curcio, D.1    Fernández, F.2    Cané, A.3    Barcelona, L.4    Stamboulian, D.5
  • 7
    • 79952325057 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease
    • Y. Cai, R. Wang, B. Liang, N. Bai, and Y. Liu Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease Antimicrob Agents Chemother 55 2011 1162 1172
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 1162-1172
    • Cai, Y.1    Wang, R.2    Liang, B.3    Bai, N.4    Liu, Y.5
  • 8
    • 80051692552 scopus 로고    scopus 로고
    • Efficacy and safety of tigecycline: a systematic review and meta-analysis
    • D. Yahav, A. Lador, M. Paul, and L. Leibovici Efficacy and safety of tigecycline: a systematic review and meta-analysis J Antimicrob Chemother 66 2011 1963 1971
    • (2011) J Antimicrob Chemother , vol.66 , pp. 1963-1971
    • Yahav, D.1    Lador, A.2    Paul, M.3    Leibovici, L.4
  • 9
    • 82455187892 scopus 로고    scopus 로고
    • Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
    • E. Tasina, A.B. Haidich, S. Kokkali, and M. Arvanitidou Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis Lancet Infect Dis 11 2011 834 844
    • (2011) Lancet Infect Dis , vol.11 , pp. 834-844
    • Tasina, E.1    Haidich, A.B.2    Kokkali, S.3    Arvanitidou, M.4
  • 10
    • 84941208313 scopus 로고    scopus 로고
    • Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs
    • F. Shen, Q. Han, D. Xie, M. Fang, H. Zeng, and Y. Deng Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs Int J Infect Dis 39 2015 25 33
    • (2015) Int J Infect Dis , vol.39 , pp. 25-33
    • Shen, F.1    Han, Q.2    Xie, D.3    Fang, M.4    Zeng, H.5    Deng, Y.6
  • 12
    • 21544449115 scopus 로고    scopus 로고
    • Estimating the mean and variance from the median, range, and the size of a sample
    • S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
    • (2005) BMC Med Res Methodol , vol.5 , pp. 13
    • Hozo, S.P.1    Djulbegovic, B.2    Hozo, I.3
  • 14
    • 84882585192 scopus 로고    scopus 로고
    • Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections
    • Y.T. Lee, S.M. Tsao, and P.R. Hsueh Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections Eur J Clin Microbiol Infect Dis 32 2013 1211 1220
    • (2013) Eur J Clin Microbiol Infect Dis , vol.32 , pp. 1211-1220
    • Lee, Y.T.1    Tsao, S.M.2    Hsueh, P.R.3
  • 16
    • 84894610175 scopus 로고    scopus 로고
    • Effectiveness of tigecycline-based versus colistin-based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis
    • Y.C. Chuang, C.Y. Cheng, W.H. Sheng, H.Y. Sun, J.T. Wang, Y.C. Chen, and et al. Effectiveness of tigecycline-based versus colistin-based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis BMC Infect Dis 14 2014 102
    • (2014) BMC Infect Dis , vol.14 , pp. 102
    • Chuang, Y.C.1    Cheng, C.Y.2    Sheng, W.H.3    Sun, H.Y.4    Wang, J.T.5    Chen, Y.C.6
  • 18
    • 84896944078 scopus 로고    scopus 로고
    • Efficacy and safety profile comparison of colistin and tigecycline on the extensively drug resistant Acinetobacter baumannii
    • S.H. Kwon, H.L. Ahn, O.Y. Han, and H.O. La Efficacy and safety profile comparison of colistin and tigecycline on the extensively drug resistant Acinetobacter baumannii Biol Pharm Bull 37 2014 340 346
    • (2014) Biol Pharm Bull , vol.37 , pp. 340-346
    • Kwon, S.H.1    Ahn, H.L.2    Han, O.Y.3    La, H.O.4
  • 19
    • 84942505201 scopus 로고    scopus 로고
    • Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study
    • A. Chaari, T. Pham, B. Mnif, K. Chtara, F. Medhioub, N. Baccouche, and et al. Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study Intensive Care Med 41 2015 2018 2019
    • (2015) Intensive Care Med , vol.41 , pp. 2018-2019
    • Chaari, A.1    Pham, T.2    Mnif, B.3    Chtara, K.4    Medhioub, F.5    Baccouche, N.6
  • 20
    • 84937578574 scopus 로고    scopus 로고
    • Excess mortality associated with colistin-tigecycline compared with colistin-carbapenem combination therapy for extensively drug-resistant Acinetobacter baumannii bacteremia: a multicenter prospective observational study
    • A. Cheng, Y.C. Chuang, H.Y. Sun, W.H. Sheng, C.J. Yang, C.H. Liao, and et al. Excess mortality associated with colistin-tigecycline compared with colistin-carbapenem combination therapy for extensively drug-resistant Acinetobacter baumannii bacteremia: a multicenter prospective observational study Crit Care Med 43 2015 1194 1204
    • (2015) Crit Care Med , vol.43 , pp. 1194-1204
    • Cheng, A.1    Chuang, Y.C.2    Sun, H.Y.3    Sheng, W.H.4    Yang, C.J.5    Liao, C.H.6
  • 21
    • 84940705768 scopus 로고    scopus 로고
    • Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
    • Aug 14, Epub ahead of print
    • S.S. Jean, T.C. Hsieh, C.W. Hsu, W.S. Lee, K.J. Bai, and C. Lam Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests J Microbiol Immunol Infect 2015 10.1016/j.jmii.2015.06.009 [Aug 14, Epub ahead of print]
    • (2015) J Microbiol Immunol Infect
    • Jean, S.S.1    Hsieh, T.C.2    Hsu, C.W.3    Lee, W.S.4    Bai, K.J.5    Lam, C.6
  • 22
    • 34250896679 scopus 로고    scopus 로고
    • Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii
    • J.J. Schafer, D.A. Goff, K.B. Stevenson, and J.E. Mangino Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii Pharmacotherapy 27 2007 980 987
    • (2007) Pharmacotherapy , vol.27 , pp. 980-987
    • Schafer, J.J.1    Goff, D.A.2    Stevenson, K.B.3    Mangino, J.E.4
  • 23
    • 38849130825 scopus 로고    scopus 로고
    • Clinical and microbiological outcomes of serious infections with multidrug-resistant Gram-negative organisms treated with tigecycline
    • K.B. Anthony, N.O. Fishman, D.R. Linkin, L.B. Gasink, P.H. Edelstein, and E. Lautenbach Clinical and microbiological outcomes of serious infections with multidrug-resistant Gram-negative organisms treated with tigecycline Clin Infect Dis 46 2008 567 570
    • (2008) Clin Infect Dis , vol.46 , pp. 567-570
    • Anthony, K.B.1    Fishman, N.O.2    Linkin, D.R.3    Gasink, L.B.4    Edelstein, P.H.5    Lautenbach, E.6
  • 24
    • 50249156755 scopus 로고    scopus 로고
    • Tigecycline for the treatment of Acinetobacter infections: a case series
    • J.C. Gallagher, and H.M. Rouse Tigecycline for the treatment of Acinetobacter infections: a case series Ann Pharmacother 42 2008 1188 1194
    • (2008) Ann Pharmacother , vol.42 , pp. 1188-1194
    • Gallagher, J.C.1    Rouse, H.M.2
  • 25
    • 63049101658 scopus 로고    scopus 로고
    • Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline
    • D. Curcio, F. Fernández, J. Vergara, W. Vazquez, and C.M. Luna Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline J Chemother 21 2009 58 62
    • (2009) J Chemother , vol.21 , pp. 58-62
    • Curcio, D.1    Fernández, F.2    Vergara, J.3    Vazquez, W.4    Luna, C.M.5
  • 26
    • 62549153583 scopus 로고    scopus 로고
    • A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline
    • N.C. Gordon, and D.W. Wareham A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline J Antimicrob Chemother 63 2009 775 780
    • (2009) J Antimicrob Chemother , vol.63 , pp. 775-780
    • Gordon, N.C.1    Wareham, D.W.2
  • 27
    • 63349106277 scopus 로고    scopus 로고
    • Tigecycline in the treatment of infections from multi-drug resistant Gram-negative pathogens
    • G. Poulakou, F.V. Kontopidou, E. Paramythiotou, M. Kompoti, M. Katsiari, E. Mainas, and et al. Tigecycline in the treatment of infections from multi-drug resistant Gram-negative pathogens J Infect 58 2009 273 284
    • (2009) J Infect , vol.58 , pp. 273-284
    • Poulakou, G.1    Kontopidou, F.V.2    Paramythiotou, E.3    Kompoti, M.4    Katsiari, M.5    Mainas, E.6
  • 28
    • 77951555223 scopus 로고    scopus 로고
    • Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections
    • G. Metan, E. Alp, O. Yildiz, D. Percin, B. Aygen, and B. Sumerkan Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections J Chemother 22 2010 110 114
    • (2010) J Chemother , vol.22 , pp. 110-114
    • Metan, G.1    Alp, E.2    Yildiz, O.3    Percin, D.4    Aygen, B.5    Sumerkan, B.6
  • 29
    • 82655173952 scopus 로고    scopus 로고
    • Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy
    • R. Guner, I. Hasanoglu, S. Keske, A.K. Kalem, and M.A. Tasyaran Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy Infection 39 2011 515 518
    • (2011) Infection , vol.39 , pp. 515-518
    • Guner, R.1    Hasanoglu, I.2    Keske, S.3    Kalem, A.K.4    Tasyaran, M.A.5
  • 30
    • 79952248676 scopus 로고    scopus 로고
    • Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients
    • S.C. Kuo, F.D. Wang, C.P. Fung, L.Y. Chen, S.J. Chen, M.C. Chiang, and et al. Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients J Microbiol Immunol Infect 44 2011 45 51
    • (2011) J Microbiol Immunol Infect , vol.44 , pp. 45-51
    • Kuo, S.C.1    Wang, F.D.2    Fung, C.P.3    Chen, L.Y.4    Chen, S.J.5    Chiang, M.C.6
  • 31
    • 84864928200 scopus 로고    scopus 로고
    • Is tigecycline a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia?
    • M.S. Tasbakan, H. Pullukcu, O.R. Sipahi, M.I. Tasbakan, S. Aydemir, and F. Bacakoglu Is tigecycline a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia? J Chemother 23 2011 345 349
    • (2011) J Chemother , vol.23 , pp. 345-349
    • Tasbakan, M.S.1    Pullukcu, H.2    Sipahi, O.R.3    Tasbakan, M.I.4    Aydemir, S.5    Bacakoglu, F.6
  • 32
    • 80054089411 scopus 로고    scopus 로고
    • The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii
    • J.J. Ye, H.S. Lin, A.J. Kuo, H.S. Leu, P.C. Chiang, C.T. Huang, and et al. The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii J Infect 63 2011 351 361
    • (2011) J Infect , vol.63 , pp. 351-361
    • Ye, J.J.1    Lin, H.S.2    Kuo, A.J.3    Leu, H.S.4    Chiang, P.C.5    Huang, C.T.6
  • 33
    • 84869471805 scopus 로고    scopus 로고
    • Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp
    • S.Y. Moon, K.R. Peck, H.H. Chang, S.W. Kim, S.T. Heo, J.S. Son, and et al. Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp Microb Drug Resist 18 2012 562 566
    • (2012) Microb Drug Resist , vol.18 , pp. 562-566
    • Moon, S.Y.1    Peck, K.R.2    Chang, H.H.3    Kim, S.W.4    Heo, S.T.5    Son, J.S.6
  • 34
    • 84864592249 scopus 로고    scopus 로고
    • Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection
    • J.A. Shin, Y.S. Chang, H.J. Kim, S.K. Kim, J. Chang, C.M. Ahn, and et al. Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection Yonsei Med J 53 2012 974 984
    • (2012) Yonsei Med J , vol.53 , pp. 974-984
    • Shin, J.A.1    Chang, Y.S.2    Kim, H.J.3    Kim, S.K.4    Chang, J.5    Ahn, C.M.6
  • 35
    • 84878022695 scopus 로고    scopus 로고
    • Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital
    • V. Avkan-Oguz, N. Yapar, S. Alp-Cavus, K. Demir Onder, E. Aktas, Z. Gulay, and et al. Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital Int J Clin Pract 67 2013 505 511
    • (2013) Int J Clin Pract , vol.67 , pp. 505-511
    • Avkan-Oguz, V.1    Yapar, N.2    Alp-Cavus, S.3    Demir Onder, K.4    Aktas, E.5    Gulay, Z.6
  • 36
    • 84901590141 scopus 로고    scopus 로고
    • High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
    • G. De Pascale, L. Montini, M. Pennisi, V. Bernini, R. Maviglia, G. Bello, and et al. High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria Crit Care 18 2014 R90
    • (2014) Crit Care , vol.18 , pp. R90
    • De Pascale, G.1    Montini, L.2    Pennisi, M.3    Bernini, V.4    Maviglia, R.5    Bello, G.6
  • 37
    • 84937562905 scopus 로고    scopus 로고
    • Clinical evaluation of tigecycline in the treatment of nosocomial infection in a hospital in Taiwan
    • M.T. Wu, H.Y. Chen, T.Y. Ou, L.N. Kuo, K.J. Cheng, and W.S. Lee Clinical evaluation of tigecycline in the treatment of nosocomial infection in a hospital in Taiwan Int J Clin Pharmacol Ther 52 2014 1030 1036
    • (2014) Int J Clin Pharmacol Ther , vol.52 , pp. 1030-1036
    • Wu, M.T.1    Chen, H.Y.2    Ou, T.Y.3    Kuo, L.N.4    Cheng, K.J.5    Lee, W.S.6
  • 38
    • 84929648571 scopus 로고    scopus 로고
    • Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure
    • B.H. Liou, Y.T. Lee, S.C. Kuo, P.Y. Liu, and C.P. Fung Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure Antimicrob Agents Chemother 59 2015 3637 3640
    • (2015) Antimicrob Agents Chemother , vol.59 , pp. 3637-3640
    • Liou, B.H.1    Lee, Y.T.2    Kuo, S.C.3    Liu, P.Y.4    Fung, C.P.5
  • 39
    • 84856944445 scopus 로고    scopus 로고
    • What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression
    • D.F. Florescu, F. Qiu, M.A. McCartan, C. Mindru, P.D. Fey, and A.C. Kalil What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression Clin Infect Dis 54 2012 670 680
    • (2012) Clin Infect Dis , vol.54 , pp. 670-680
    • Florescu, D.F.1    Qiu, F.2    McCartan, M.A.3    Mindru, C.4    Fey, P.D.5    Kalil, A.C.6
  • 40
    • 17644389620 scopus 로고    scopus 로고
    • Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections
    • M.E. Falagas, and S.K. Kasiakou Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections Clin Infect Dis 40 2005 1333 1341
    • (2005) Clin Infect Dis , vol.40 , pp. 1333-1341
    • Falagas, M.E.1    Kasiakou, S.K.2
  • 41
    • 84925841586 scopus 로고    scopus 로고
    • Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis
    • W. Ni, X. Cai, C. Wei, X. Di, J. Cui, R. Wang, and et al. Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis Braz J Infect Dis 19 2015 170 180
    • (2015) Braz J Infect Dis , vol.19 , pp. 170-180
    • Ni, W.1    Cai, X.2    Wei, C.3    Di, X.4    Cui, J.5    Wang, R.6
  • 42
    • 84902585467 scopus 로고    scopus 로고
    • Efficacy and safety of polymyxins for the treatment of Acinetobacter baumannii infection: a systematic review and meta-analysis
    • Q. Liu, W. Li, Y. Feng, and C. Tao Efficacy and safety of polymyxins for the treatment of Acinetobacter baumannii infection: a systematic review and meta-analysis PLOS ONE 9 2014 e98091
    • (2014) PLOS ONE , vol.9
    • Liu, Q.1    Li, W.2    Feng, Y.3    Tao, C.4
  • 43
    • 80054762740 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic evaluation of tigecycline
    • H. Giamarellou, and G. Poulakou Pharmacokinetic and pharmacodynamic evaluation of tigecycline Expert Opin Drug Metab Toxicol 7 2011 1459 1470
    • (2011) Expert Opin Drug Metab Toxicol , vol.7 , pp. 1459-1470
    • Giamarellou, H.1    Poulakou, G.2
  • 44
    • 19544371022 scopus 로고    scopus 로고
    • Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline
    • J.E. Conte Jr., J.A. Golden, M.G. Kelly, and E. Zurlinden Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline Int J Antimicrob Agents 25 2005 523 529
    • (2005) Int J Antimicrob Agents , vol.25 , pp. 523-529
    • Conte, J.E.1    Golden, J.A.2    Kelly, M.G.3    Zurlinden, E.4
  • 46
    • 84911003547 scopus 로고    scopus 로고
    • Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review
    • P. Poulikakos, G.S. Tansarli, and M.E. Falagas Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review Eur J Clin Microbiol Infect Dis 33 2014 1675 1685
    • (2014) Eur J Clin Microbiol Infect Dis , vol.33 , pp. 1675-1685
    • Poulikakos, P.1    Tansarli, G.S.2    Falagas, M.E.3
  • 47
    • 84902539127 scopus 로고    scopus 로고
    • Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections
    • M.E. Falagas, K.Z. Vardakas, K.P. Tsiveriotis, N.A. Triarides, and G.S. Tansarli Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections Int J Antimicrob Agents 44 2014 1 7
    • (2014) Int J Antimicrob Agents , vol.44 , pp. 1-7
    • Falagas, M.E.1    Vardakas, K.Z.2    Tsiveriotis, K.P.3    Triarides, N.A.4    Tansarli, G.S.5
  • 48
    • 50149096410 scopus 로고    scopus 로고
    • Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
    • N. Petrosillo, E. Ioannidou, and M.E. Falagas Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies Clin Microbiol Infect 14 2008 816 827
    • (2008) Clin Microbiol Infect , vol.14 , pp. 816-827
    • Petrosillo, N.1    Ioannidou, E.2    Falagas, M.E.3
  • 49
    • 79951880812 scopus 로고    scopus 로고
    • Can pharmacokinetic and pharmacodynamic principles be applied to the treatment of multidrug-resistant Acinetobacter?
    • T.W. Cooper, S.E. Pass, S.D. Brouse, and R.G. Hall Can pharmacokinetic and pharmacodynamic principles be applied to the treatment of multidrug-resistant Acinetobacter? Ann Pharmacother 45 2011 229 240
    • (2011) Ann Pharmacother , vol.45 , pp. 229-240
    • Cooper, T.W.1    Pass, S.E.2    Brouse, S.D.3    Hall, R.G.4
  • 51
    • 66149085768 scopus 로고    scopus 로고
    • Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis
    • B.A. Cunha Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis J Clin Microbiol 47 2009 1613
    • (2009) J Clin Microbiol , vol.47 , pp. 1613
    • Cunha, B.A.1
  • 52
    • 84875180696 scopus 로고    scopus 로고
    • Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia
    • J. Ramirez, N. Dartois, H. Gandjini, J.L. Yan, J. Korth-Bradley, and P.C. McGovern Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia Antimicrob Agents Chemother 57 2013 1756 1762
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 1756-1762
    • Ramirez, J.1    Dartois, N.2    Gandjini, H.3    Yan, J.L.4    Korth-Bradley, J.5    McGovern, P.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.